Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Breakthrough designation is pivotal

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Apr 22, 2022 4:18pm

103 Views

Post# 34625078

RE:RE:RE:RE:Breakthrough designation is pivotal

FFS Gorf. Give it a rest and don't act like a child. What is wrong with you? You don't think TLT's management want share price to rise? Well, then you have to ask the same question to EVERY company's management out there that is at 30 cents or have lost share value when a PR was met well. Wait 6 months for more patients to arrive with results. Or is that too long for you?

Be a man.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing